Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.
Saved in:
| Title: | Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial. |
|---|---|
| Authors: | D'Alise AM; Nouscom SRL, Rome, Italy., Willis J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duzagac F; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hall MJ; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA., Cruz-Correa M; University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA., Idos GE; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Thirumurthi S; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ballester V; University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA., Leoni G; Nouscom SRL, Rome, Italy., Garzia I; Nouscom SRL, Rome, Italy., Antonucci L; Nouscom SRL, Rome, Italy., De Marco L; Nouscom SRL, Rome, Italy., Micarelli E; Nouscom SRL, Rome, Italy., Deng N; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Seclì L; Nouscom SRL, Rome, Italy., Gogov S; Nouscom AG, Basel, Switzerland., Dong W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jack Lee J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bowen CM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vornik LA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Gonzalez A; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Richmond E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA., Umar A; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA., Brown PH; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sinha KM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez LM; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.; Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD, USA., Scarselli E; Nouscom SRL, Rome, Italy. e.scarselli@nouscom.com., Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. EVilar@mdanderson.org. |
| Source: | Nature medicine [Nat Med] 2026 Mar; Vol. 32 (3), pp. 1002-1011. Date of Electronic Publication: 2026 Jan 16. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41545594 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22D'Alise+AM%22">D'Alise AM</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Willis+J%22">Willis J</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Duzagac+F%22">Duzagac F</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hall+MJ%22">Hall MJ</searchLink>; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cruz-Correa+M%22">Cruz-Correa M</searchLink>; University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA.<br /><searchLink fieldCode="AU" term="%22Idos+GE%22">Idos GE</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Thirumurthi+S%22">Thirumurthi S</searchLink>; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ballester+V%22">Ballester V</searchLink>; University of Puerto Rico Medical Sciences Campus, San Juan, PR, USA.<br /><searchLink fieldCode="AU" term="%22Leoni+G%22">Leoni G</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Garzia+I%22">Garzia I</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Antonucci+L%22">Antonucci L</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22De+Marco+L%22">De Marco L</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Micarelli+E%22">Micarelli E</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Deng+N%22">Deng N</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Seclì+L%22">Seclì L</searchLink>; Nouscom SRL, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Gogov+S%22">Gogov S</searchLink>; Nouscom AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dong+W%22">Dong W</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jack+Lee+J%22">Jack Lee J</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bowen+CM%22">Bowen CM</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Vornik+LA%22">Vornik LA</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Garcia-Gonzalez+A%22">Garcia-Gonzalez A</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Reyes-Uribe+L%22">Reyes-Uribe L</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Richmond+E%22">Richmond E</searchLink>; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Umar+A%22">Umar A</searchLink>; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Brown+PH%22">Brown PH</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sinha+KM%22">Sinha KM</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+LM%22">Rodriguez LM</searchLink>; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.; Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Scarselli+E%22">Scarselli E</searchLink>; Nouscom SRL, Rome, Italy. e.scarselli@nouscom.com.<br /><searchLink fieldCode="AU" term="%22Vilar+E%22">Vilar E</searchLink>; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. EVilar@mdanderson.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2026 Mar; Vol. 32 (3), pp. 1002-1011. <i>Date of Electronic Publication: </i>2026 Jan 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41545594 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-025-04182-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1002 Titles: – TitleFull: Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: D'Alise AM – PersonEntity: Name: NameFull: Willis J – PersonEntity: Name: NameFull: Duzagac F – PersonEntity: Name: NameFull: Hall MJ – PersonEntity: Name: NameFull: Cruz-Correa M – PersonEntity: Name: NameFull: Idos GE – PersonEntity: Name: NameFull: Thirumurthi S – PersonEntity: Name: NameFull: Ballester V – PersonEntity: Name: NameFull: Leoni G – PersonEntity: Name: NameFull: Garzia I – PersonEntity: Name: NameFull: Antonucci L – PersonEntity: Name: NameFull: De Marco L – PersonEntity: Name: NameFull: Micarelli E – PersonEntity: Name: NameFull: Deng N – PersonEntity: Name: NameFull: Seclì L – PersonEntity: Name: NameFull: Gogov S – PersonEntity: Name: NameFull: Dong W – PersonEntity: Name: NameFull: Jack Lee J – PersonEntity: Name: NameFull: Bowen CM – PersonEntity: Name: NameFull: Vornik LA – PersonEntity: Name: NameFull: Garcia-Gonzalez A – PersonEntity: Name: NameFull: Reyes-Uribe L – PersonEntity: Name: NameFull: Richmond E – PersonEntity: Name: NameFull: Umar A – PersonEntity: Name: NameFull: Brown PH – PersonEntity: Name: NameFull: Sinha KM – PersonEntity: Name: NameFull: Rodriguez LM – PersonEntity: Name: NameFull: Scarselli E – PersonEntity: Name: NameFull: Vilar E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 32 – Type: issue Value: 3 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |